Literature DB >> 20921464

Compliance with tamoxifen in women with breast cancer and a BRCA1 or BRCA2 mutation.

Steven A Narod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20921464     DOI： 10.1200/JCO.2010.31.5770

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

Review 1.  Recent progress and clinical importance on pharmacogenetics in cancer therapy.

Authors:  Thomas I Peng Soh; Wei Peng Yong; Federico Innocenti
Journal:  Clin Chem Lab Med       Date:  2011-09-28       Impact factor: 3.694

2.  Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Jacek Gronwald; Andre Robidoux; Charmaine Kim-Sing; Nadine Tung; Henry T Lynch; William D Foulkes; Siranoush Manoukian; Peter Ainsworth; Susan L Neuhausen; Rochelle Demsky; Andrea Eisen; Christian F Singer; Howard Saal; Leigha Senter; Charis Eng; Jeffrey Weitzel; Pal Moller; Dawna M Gilchrist; Olufunmilayo Olopade; Ophira Ginsburg; Ping Sun; Tomasz Huzarski; Jan Lubinski; Steven A Narod
Journal:  Breast Cancer Res Treat       Date:  2014-06-21       Impact factor: 4.872

3.  Battling prostate cancer with 5-alpha-reductase inhibitors: a pyrrhic victory?

Authors:  Richard M Hoffman; Richard G Roberts; Michael J Barry
Journal:  J Gen Intern Med       Date:  2011-01-11       Impact factor: 5.128

4.  A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer.

Authors:  Alison Harrow; Ruth Dryden; Colin McCowan; Andrew Radley; Mark Parsons; Alastair M Thompson; Mary Wells
Journal:  BMJ Open       Date:  2014-06-12       Impact factor: 2.692

5.  Statin pharmacogenomics: opportunities to improve patient outcomes and healthcare costs with genetic testing.

Authors:  William J Canestaro; David G Brooks; Donald Chaplin; Niteesh K Choudhry; Elizabeth Lawler; Lori Martell; Troyen Brennan; E Robert Wassman
Journal:  J Pers Med       Date:  2012-10-17

6.  Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.

Authors:  B Makubate; P T Donnan; J A Dewar; A M Thompson; C McCowan
Journal:  Br J Cancer       Date:  2013-03-21       Impact factor: 7.640

7.  The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.

Authors:  C McCowan; S Wang; A M Thompson; B Makubate; D J Petrie
Journal:  Br J Cancer       Date:  2013-08-15       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.